SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009519
Filing Date
2020-08-06
Accepted
2020-08-06 08:31:01
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20200630x10q.htm   iXBRL 10-Q 1172289
2 EX-31.1 albo-20200630xex31d1.htm EX-31.1 10355
3 EX-31.2 albo-20200630xex31d2.htm EX-31.2 10320
4 EX-32.1 albo-20200630xex32d1.htm EX-32.1 10499
  Complete submission text file 0001558370-20-009519.txt   3560979

Data Files

Seq Description Document Type Size
5 EX-101.SCH albo-20200630.xsd EX-101.SCH 29525
6 EX-101.CAL albo-20200630_cal.xml EX-101.CAL 31539
7 EX-101.DEF albo-20200630_def.xml EX-101.DEF 65428
8 EX-101.LAB albo-20200630_lab.xml EX-101.LAB 254116
9 EX-101.PRE albo-20200630_pre.xml EX-101.PRE 172670
10 EXTRACTED XBRL INSTANCE DOCUMENT albo-20200630x10q_htm.xml XML 436444
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 201079986
SIC: 2834 Pharmaceutical Preparations